Analysis shows improved specific absorption rate in magnetic fluid hyperthermia with PEG-400 enhancing biocompatibility.
This article presents the synthesis and comprehensive investigation of the static and dynamic magnetization properties of large-scale PEG-400-coated superparamagnetic ZnxMn1-xFe₂O₄ (0 ≤ × ≤ 0.8) nanoparticles, highlighting their potential use as magnetic carriers in magnetic fluid hyperthermia (MFH). The Rietveld analysis of the X-ray diffraction spectra confirmed that the surface-functionalized core nanoparticles exhibit a single-phase spinel structure at the nanoscale, ranging from 15.4 to 11.2 nm. The use of PEG-400 as a hydrophilic shell over Mn-Zn ferrite enhances colloidal stability, as evidenced by the elevated zeta potential (ζ) values ranging from -40 to -26 mV. This enhancement reflects an increase in electrostatic repulsion among ZnxMn1-xFe₂O₄ nanoparticles, making them well-suited for formulating viscoelastic and water-based magnetic fluids for hyperthermia applications. The AC inductive heating efficiency for magnetic hyperthermia was systematically investigated as a function of particle concentration, applied alternating magnetic field (AMF), and radiofrequency. To optimize hyperthermic performance, AMF strengths of 9.5 kA/m, 18.3 kA/m, and 25.4 kA/m were applied at corresponding constant frequencies of 586.4 kHz, 154.8 kHz, and 103 kHz, using nanoparticle concentrations of 3 and 6 mg/mL. The optimal heating performance, with maximum specific absorption rate and intrinsic loss power (ILP) values of 273.4 W/g and 5.271 nHm²/kg, respectively, was achieved at 18.3 kA/m and 154.8 kHz for a 3 mg/mL concentration, which was comparable to clinically approved magnetic hyperthermia fluids (ILP range: 0.15-3.1 nHm²/kg). At the highest tested frequency (586.4 kHz), the system deviated from linear response theory, further enhancing heating efficiency due to nonlinear Brownian and Neel relaxation processes. The ZnxMn1-xFe₂O₄ MNPs exhibit good biocompatibility (95-70% cell viability) with tested concentrations of 50, 100, 250, 500, and 1000 μM over HeLa cell lines.
No takes yet. Share an insight, caveat, or question.
Rao et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: